Related content

Clinical characteristics of brain metastases from lung cancer according to histological type: Pretreatment evaluation and survival following whole-brain radiotherapy

By          

Molecular and Clinical Oncology, Vol. 1, Iss. 4, 2013-01 ,pp. : 692-698

Spandidos Publications

Access to resources Recommend Favorite

Evaluation of PTEN loss and PIK3CA mutations and their correlation with efficacy of trastuzumab treatment in HER2-positive metastatic breast cancer: A retrospective study (KBC-SG 1001)

By Nishimura  

Molecular and Clinical Oncology, Vol. 1, Iss. 1, 2013-01 ,pp. : 47-52

Spandidos Publications

Access to resources Recommend Favorite

Exon 20 PIK3CA mutations decreases survival in aggressive (HER-2 positive) breast carcinomas

By Lerma Enrique  

Virchows Archiv, Vol. 453, Iss. 2, 2008-08 ,pp. : 133-139

Springer Publishing Company

Access to resources Recommend Favorite

Humoral Epitope-Spreading Following Immunization with a HER-2/neu Peptide Based Vaccine in Cancer Patients

By Disis Mary L.   Goodell Vivian   Schiffman Kathy   Knutson Keith L.  

Journal of Clinical Immunology, Vol. 24, Iss. 5, 2004-09 ,pp. : 571-578

Springer Publishing Company

Access to resources Recommend Favorite

Collagen gel droplet-embedded culture-drug sensitivity test and Ki67 expression in estrogen receptor-positive and HER2-negative breast cancer

By Tozuka  

Molecular and Clinical Oncology, Vol. 1, Iss. 1, 2013-01 ,pp. : 93-99

Spandidos Publications

Access to resources Recommend Favorite